|
Mueller Medical Intl LLC Product Pipeline in North America
The Product Development Program of Mueller Medical is calculated
below.
|
VETERINARY
PRODUCT PIPELINE IN NORTH AMERICA (Supplement-Based
SOS-Enhanced) |
|
|
PRODUCT |
INDICATION |
Pre-Clinical/Phase I |
Phase
II/III |
Pre-Market |
In Market
|
|
Rx Suppl |
Equine
Gastrafate |
Erosions,
Colitic Diarrhea, Colic |
xx |
xx |
xx |
xx |
|
Rx Suppl |
Dog-Cat
Gastrafate |
Gastritis, Vomiting, Diarrhea |
xx |
xx |
xx |
xx |
|
|
|
|
|
|
|
|
|
Rx Device |
Equine
Dermafate |
Epidermal
Wounds |
xx |
|
|
|
|
Rx Device |
Dog-Cat
Dermafate |
Epidermal
Wounds |
xx |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OTC
4 Types |
Equine
Gastralox
Trainers/Owners
Foal/ Train&Show |
Low Grade
Colic, Poor Appetite |
xx |
xx |
xx |
xx |
|
OTC Suppl |
Canine
Gastralox |
Vomiting
Diarrhea |
xx |
xx |
xx |
xx |
|
OTC Suppl |
Feline
Gastralox |
Vomiting
Diarrhea |
xx |
xx |
xx |
xx |
|
OTC Suppl |
Cainine
ColoGastro |
Vomiting
Diarrhe |
xx |
xx |
xx |
xx |
|
OTC Suppl |
Feline
ColoGastro |
Vomiting
Diarrheaa |
xx |
xx |
xx |
xx |
|
|
HUMAN PRODUCT
PIPELINE IN THE NORTH AMERICA |
|
|
PRODUCT |
INDICATION |
Pre-Clinical/Phase I |
Phase
II/III |
Pre-Market/NDA |
In Market |
|
Rx Drug |
GastrafateRx |
Functional Dyspepsia |
xx |
xx |
|
|
|
Rx Drug |
GastrafateIB |
IBS, All
3 Forms |
xx |
xx |
|
|
|
Rx Drug |
GastrafateLoAl |
GERD |
xx |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rx Device |
OraEsophate |
Pediatric/Adult Mucosal Lesions |
xx |
xx |
xx Pre
Market Notification |
xx
Mid-Late 2007 |
|
Rx Device |
Dermafate
Wound |
Pediatric/Adult Epidermal Wounds |
xx |
xx |
xx Pre
Market Notification |
xx
Mid-Late 2007 |
|
Rx Device |
Dermafate
Burn |
Pediatric/Adult Epidermal Burns |
XX |
xx |
xx Pre
Market Notification |
xx
Mid-Late 2007 |
|
|
|
|
|
|
|
|
|
OTC Suppl |
ColoGastro |
Upset
Stomach-Diarrhea-Heartburn |
xx |
xx |
xx |
xx 2006 |
|
OTC Suppl |
Caralox |
Heartburn
|
xx |
xx |
xx |
xx 2004 |
|
OTC Suppl |
Caralox
Phyto |
Heartburn, Severe |
xx |
xx |
xx |
xx 2004 |
|
OTC Suppl |
IBS/Regulan |
Irritable
Bowel Irregularity |
xx |
xx |
xx |
xx 2005 |
|
OTC Suppl |
TriFiberlan |
Fiber
Irregularity |
xx |
xx |
xx |
xx 2006 |
|
|
PRODUCT PIPELINE FOR
HUMAN APPLICATION IN INDIA |
|
|
PRODUCT
|
INDICATION |
Pre-Clinical/Phase I |
Phase
II/III |
Pre-Market |
In Market |
|
Rx Drug |
GastrafateRx |
Functional Dyspepsia |
xx |
xx |
xx |
xx 2005
|
|
Rx Drug |
GastrafateIB |
IBS, All
3 Forms |
xx |
xx |
xx |
xx 2006 |
|
Rx Drug |
GastrafateLoAl |
GERD |
xx |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rx Device |
OraEsophate |
Pediatric/Adult Mucosal Lesions |
xx |
xx |
|
xx
Late 2007 |
|
Rx Device |
Dermafate
Wound |
Pediatric/Adult Epidermal Wounds |
xx |
xx |
xx |
xx Late
2007 |
|
Rx Device |
Dermafate
Burn |
Pediatric/Adult Epidermal Burns |
XX |
xx |
xx |
|
|
|
|
|
|
|
|
|
|
OTC |
| |
